Oxygen Concentrator Market - Industry Analysis, Size, Share, Growth and Forecast, 2024- Hexa Research

An oxygen concentrator is a device used to deliver concentrated oxygen to a patient requiring oxygen therapy. These devices are considered as a safer, easy to use and inexpensive compared to compressed oxygen cylinders. Portable oxygen concentrator acts by increasing the concentration of oxygen by taking a mixture air from its surrounding. Major factors expected to drive the market for oxygen concentrators include its ability to provide oxygen under all circumstances and worldwide aging population coupled with COPD and other respiratory diseases.

The older versions of the oxygen concentrators were considered to be unreliable and difficult to use as they were bulky and costly. Over the past years, oxygen concentrators have been evolved as manufacturers are improving the design of them and by manufacturing them with a relatively smaller size & higher mobility. The market for oxygen concentrators has undergone significant changes and improvement with the introduction of portable technology. The devices have become lighter, more powerful and affordable leading to increasing demand in the homecare department.

Increasing worldwide geriatric population means rise in homecare oxygen treatment. People with respiratory conditions such as chronic obstructive pulmonary disease (COPD), chronic bronchitis and emphysema have benefitted greatly with innovations in oxygen concentrator technology. Some of the new and improved versions of the standard large and bulky devices include AirSep’s Lifestyle portable oxygen concentrator, Inogen One G3, VBOX Trooper, EverGo, Invacare XPO2 and iGo.

Browse Details of the Report @ https://www.hexaresearch.com/research-report/oxygen-concentrator-market

The demand for lighter technology by consumers and need for better mobility support for the aged rises, new competitors enter the market thereby driving innovations. This has resulted in high-quality devices at lower prices. The global oxygen concentrator market is segmented by types, application and geography. On the basis of types, the global oxygen concentrator market is segmented into portable oxygen concentrator, stationary oxygen concentrator and so on.

On the basis of application, the global oxygen concentrator market is segmented into medical, water treatment, pharmaceutical production, glass manufacture and so on. On the basis of geography, the global oxygen concentrator market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Asia Pacific Excluding Japan oxygen concentrators market is projected to register a significant CAGR during the forecast period. Improving economic conditions is fuelling the growth of the global oxygen concentrators market in Asia Pacific.

The U.S. accounts for the largest share of the global oxygen concentrator market followed by Europe, due to growing consumer awareness rising incidences of COPD and demographic changes. COPD is known to be the fourth leading cause of death in the U.S. and the number has been dangerously rising, increasing the use of respiratory care devices. The change in lifestyle across the globe has led to an alarming rise in smoking population which has also fuelled the growth of the oxygen concentrator market.

The key players of global oxygen concentrator market are Braun and Company, Air Liquide, CareFusion, Chart Industries, Covidien, DeVilbiss Healthcare, Drive Medical, Fanem, Fisher & Paykel Healthcare, Bio-Med Devices, Invacare Philips Healthcare, Jiangxi Teli Anesthesia, Respiration Equipment, Newport Medical Instruments Inc., Respironics, Providence Global Medical, Percussionaire Corporation, Vortran Medical Technology, Intersurgical Ltd., Smiths Medical WinterGreen Research Inc., Eget Hi-Tec Co. Ltd., Race Medical and Beauty Equipments and Maquet.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Visit Our Blog - hexaresearch1.blogspot.com

Gastroscope Market Trends, Growth,Size and Forecasts to 2021: Hexa Research

Gastroscopy (also known as an upper GI endoscopy) is a procedure that enables a gastroenterologist to examine the lining of the upper part of your gastrointestinal tract, i.e. the esophagus (swallowing tube), stomach, and duodenum (first portion of the small intestine) using a thin flexible tube that has a camera lens and light source.

Gastrointestinal Endoscope is a device or an instrument that allows a doctor or surgeon to look inside the body through existing openings or through small incisions. These instruments are used for inspecting the internal lining of the gastrointestinal tract. They help in detecting the cause of abdominal bleeding, any persistent pain, vomiting, tumor affecting the GI tract, inflation, etc. Any infections or abnormalities in function of this GI tract are detected by means of gastrointestinal endoscopic devices.

Gastroscopy is more accurate than X-Ray films for detecting inflammation, ulcers, or tumors of the esophagus, stomach, and duodenum. Biopsies (small tissue samples) may be taken at the time of your gastroscopy.The instrument used is called Gastroscope, a flexible tube with a diameter less than that of a little finger. The gastroscope has light and a camera at the end. The camera sends pictures of the lining of your esophagus, stomach, and duodenum to a screen, where the endoscopist is able to look at them. All through the examination, the endoscopist may need to take some small tissues samples, called biopsies, for analysis under a microscope in lab.

Browse Details of "Gastroscope Market" Report @ https://www.hexaresearch.com/research-report/gastroscope-market

Gastrointestinal endoscopy is an industry driven by quickly evolving technology, an aging population all through the globe, and the augmented recognition of problems associated with morbid obesity that can sometimes be addressed by relatively noninvasive or minimally invasive actions. There are many drivers for this market, counting the evolution of technology so that many endoscopic-related diagnostic procedures are noninvasive, and the growing requirements by employer-based and government-funded health insurance companies for covered insurance members.

The endoscope is a metal tube that has a small light source and camera at one end and an eyepiece at the other. Endoscopes may be made from an inflexible tube or, additional often, from a flexible tube that allows the surgeon to generously move and regulate it as it enters the area that is being observed. Upgraded designs of the equipment have also made flexible GI endoscopes easier to handle, and smaller instrumentation has permitted for more dedicated devices. As such kind of developments take place in the market; they will drive growth in unit sales, which will drive growth in the market value. Global Gastrointestinal Endoscope Market is segmented by Segment (Colonoscopy, Gastroscope, Duodenoscope and Eosophagoscopes). Global Gastrointestinal Endoscope Market is segmented By Type (Rigid and Flexible endoscopes [Video and Non-Video Endoscopes]). Global Gastroscope Market is segmented By Symptoms into Gastroscopy Persistent heartburn, Bleeding, Nausea and Vomiting, Pain, Problems Swallowing, Unexplained weight loss. Global Gastroscope Market is segmented By Geographical Region into North America, China, Europe, Japan, India, and Southeast Asia.

Increased demand for advanced endoscopy devices is coming from emerging markets like Japan and Vietnam. The other countries like India, China, Brazil, and Russia are also experiencing rapid growth due to recognition of this technology as well as increased middle class population is these countries, which are also increasing the demand for advanced medical devices. The key Players include Olympus, Pentax, FUJIFILM Holdings, Stryker, Hoya, HMB Endoscopy Products, Cook Medical Shanghail AOHUA, Bostan Scientific, and Advanced Endoscopy Devices.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry/

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Visit our Blog: hexaresearch1.blogspot.com

Pharmacy Automation Devices Market may Exceed USD 8 billion by 2020: Hexa Research

The Pharmacy Automation Devices Market is anticipated to expand at a CAGR nearly 7.4% during the forecast period (2014 to 2020). Revenues may surpass USD 8 billion by 2020. Mechanical processes that are used in the handling and distribution of medications are known as pharmacy automation. Pharmacies employ automation in order to enhance cash flows and bring down medication inventories. Devices that facilitate these tasks are known as pharmacy automation devices. High incidence of medical error deaths is one of the key drivers of this industry.

Computerized physician order entry, EHR (electronic health record), and clinical decision support system are some of the commonly used devices. These help monitor patients on a regular basis so that their health conditions are better understood. High investments in research & development and growing popularity of medical automation may augment industry growth over the forecast period. Other market drivers are need for minimal medical errors, greater consciousness about advanced pharmacy, and high population growth. Furthermore, demand for minimally invasive surgical procedures with integrated medical automation could propel the industry in the forthcoming years.

Browse Details of Report@

https://www.hexaresearch.com/research-report/pharmacy-automation-device-industry

Applications, end-use, and regions are the three parameters based on which the global pharmacy automation devices market is categorized. Based on applications, the segments are automated medication dispensing systems, automated medication & compounding systems, automated storage & retrieval systems, table top tablet counters, and automated packaging & labeling systems. Packaging & labeling instruments mainly include deblistering machines, sealers, printing solutions, and fillers & sealers.

Automated medication dispensing systems enable computer controlled storage, tracking, dispensation, and the efficient recording of medical works. This segment held the highest market share in 2013. Unlike small sized hospitals that face budgetary constraints, highly established & large hospitals mainly adopt automated medication dispensing systems. Dispensing cabinets help healthcare practitioners to provide medications in a systematic manner and keep a record of the same in the overall system.  

Retail pharmacy and hospital pharmacy are the two main end-users in the overall industry. Owing to robust investments, the hospital pharmacy segment may witness remarkable growth till 2020. It is sub-segmented into central pharmacy automation solutions, pharmacy robots, barcode medication dispensing, and point-of-care automation solutions among others.

Geographically, the worldwide pharmacy automation devices industry is divided into Asia Pacific, North America, Europe, and Rest of the World. In revenue terms, North America dominated the overall industry in 2013. Regional drivers are technological developments, the need for minimal medical errors, and a rapidly growing aging population. Asia Pacific is projected to be the fastest growing region in the forecast period. Factors that could positively impact the region are high income levels and greater awareness about the benefits of medical automation.

Prominent players in the global Pharmacy Automation Devices Market are Innovation PharmaAssist Robotics, Pyxis Pharmacy Automation Systems, McKesson Corporation, CareFusion Corporation, Accu Chart Healthcare, and Swisslog Holding Ltd. TCGRx, a Wisconsin based company dealing in pharmacy automation declared the development of PillBot™ in November 2016. PillBot™ is a pharmacy automation device that enables the filling of multi-dose and unit-dose cards in addition to pouch packaging. It can efficiently package medicines in blister formats as well as in pouch formats. The product will soon be launched this year.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Visit Our Blog - hexaresearch1.blogspot.com

Pharmacovigilance Market Analysis, Growth, Industry Trends and Forecast to 2020 - Hexa Research

The global Pharmacovigilance Market is expected to grow at a CAGR nearly 9.7% during the forecast period (2014 to 2020). This industry was valued at approximately USD 2410 million in 2013. High incidence of adverse drug reaction (ADR) and stringent regulatory norms pertaining to drug safety drive the overall industry. Pharmacovigilance, also known as drug safety involves testing the effects of medical drugs once these have been approved & licensed for use. This is done basically to identify & evaluate adverse reactions that had gone unreported in the past.

It utilizes pharmacological science that helps in the collection, assessment, detection, monitoring, and prevention of drug reactions after pharmaceutical drugs have been consumed. Issues of drug toxicity, rising cases of chronic ailments, and an ever-expanding geriatric population cumulatively impact overall industry demand.

Browse Details of Report@

https://www.hexaresearch.com/research-report/pharmacovigilance-industry

The worldwide pharmacological market is categorized on the basis of clinical trials, types of methods, service types, and geographies. As per clinical trial phases, the segments are preclinical, phase 0, phases I, II, III, and IV. The usage rate was by far the highest for phase IV in 2013. Before getting the nod from regulatory authorities, phase IV needs to necessarily clear the following vital stages: quality inspection, efficacy test, and safety of use. Data gathered during the post phase III stage is highly reliable & widely accepted. The phase IV trials market holds the largest share, closely followed by the phase III market. As against phase I & II, phase III witnesses maximum drug safety clearances.

Based on types of methods, the global Pharmacovigilance Market is categorized into intensified ADR reporting, cohort event monitoring, target reporting, EHR monitoring, and spontaneous reporting. The EHR monitoring segment may expand robustly during the forecast period. This market is fueled by the growing trend of automation & digitalization in healthcare. EHR devices facilitate effective communications between doctors and patients owing to efficient data sharing capabilities electronically.

House manufacturing and contract outsourcing are two types of services in the pharmacovigilance market. Contractual outsourcing led the industry in 2013. Due to globalization, developed countries can manufacture goods & services at affordable costs because of outsourcing. Outsourcing leads to lower production failures and helps overcome the problem of depleting stocks. It could even lower fixed costs, facilitate effective resource management, mitigate risks, and reduce upfront investments.

Geographically, the global pharmacovigilance industry is divided into Europe, North America, and Asia Pacific. North America dominated the industry in 2013. Implementation of drug safety regulatory norms by FDA and substantial R&D investments are key regional drivers. Asia Pacific could expand robustly during the forecast period because of availability of cheap labor and widespread awareness about ADR. This region offers several lucrative opportunities for further market progress.

Prominent competitors in the worldwide pharmacovigilance market are Janssen Research & Development, United BioSource Corporation, Cognizant Technology Solutions Corporation, Boehringer Ingelheim Gmbh, and Bristol-Myers Squibb. Most companies engage in business ventures, such as mergers and acquisitions in order to gain higher market shares.

The life sciences industry is a rapidly developing one. Advanced automation is gaining much importance in this industry as it is in the others. While most life sciences companies aim at launching products rapidly & cost effectively, they also need to ensure other key aspects. The devices & drugs being produced, besides fulfilling patient needs, must lead to better outcomes in the short & long term. A number of life sciences organizations have adopted automation for modernization of core enterprise systems. These have proved useful in many ways. In pharmacovigilance, it plays a key role in quality measurement, quantitative studies, customer service, data capture, and cognitive learning for medical report analysis, and others.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Visit Our Blog - hexaresearch1.blogspot.com

Dental Equipment Market Trends, Growth, Industry Analysis and Forecast to 2020 | Hexa Research

The global Dental Equipment Market is poised to reach nearly USD 8.5 billion by 2020. The industry is driven by high incidence of dental infections & diseases. Unhealthy eating habits and rising consumption of junk foods, alcohol, chocolates, and tobacco are factors that propel demand for dental equipment. The industry is led by technological innovations that lead to simplicity & cost effectiveness. Rising cases of periodontal diseases and dental caries could propel the market for tooth implantations over the forecast period (2012 to 2020). Demand for dental radiology equipment may also increase significantly during this time because of enhanced quality and higher efficiency.

Other global industry drivers are availability of sophisticated technologies, growing geriatric population, and growing cases of tooth loss. Medical tourism too may positively influence the overall industry. The dental equipment market in most emerging economies could witness robust growth in the forthcoming years. This attributes to greater consciousness among the masses about the significance of dental health & hygiene. However, high costs of sophisticated technologies in dentistry and surging demand for refurbished dental equipment are factors that hinder industry growth. 

Browse Details of Report @ https://www.hexaresearch.com/research-report/dental-equipment-industry

The global dental equipment market is segmented on the basis of products and regions. As per products, the classifications are hygiene maintenance devices, dental radiology equipment, systems & parts, laboratory machines, dental lasers, and others. “Others” includes chairs, hand piece, light cure, and scaling unit. Dental systems & parts generated the highest revenues in the overall market in 2013. Due to technological advancements, this segment may continue dominating the industry throughout the forecast period.

The dental systems & parts segment is further divided into the following: furnace & ovens, cone beam Ct systems, cast machine, instrument delivery systems, electrosurgical equipment, vacuums & compressors, CAD (computer-aided design) /CAM (computer-aided manufacturing) and other system & parts. In revenue terms, CAD/CAM held the highest market share in 2013 and may continue leading the industry in the near future.

Geographically, the global industry is categorized into Asia Pacific, Europe, North America, and Rest of the World. North America dominated the industry in terms of revenue in 2013. Regional drivers are technological developments in healthcare, substantial investments in research & development, and growing geriatric population. Asia Pacific economies, such as Brazil, Japan, China, South Korea, and India could witness significant market growth during the forecast period. Owing to gaps in demand & supply of dental treatment, these regions offer a host of opportunities for further market progress. Prominent companies operating in the overall industry are Planmeca Oy, BIOLASE Technology, Ivoclar Vivadent, Danaher Corporation, and Dentsply International. Characterized by stiff competition, the market witnesses frequent business ventures and new product developments.

In December 2016, DenMat launched the VisiLite Pro, an oral lesion screening device that is based on light based fluorescence technology. This system helps detect epithelial dysplasia in its early stages. Dentists can effectively incorporate this system into the conventional neck and head exam in order to rule out oral cancer. Fluorescence visualization offers entirely new visual information which is quite different from what doctors get while looking at reflected lights from chemiluminescent or white light sources.

 Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Visit our Blog: hexaresearch1.blogspot.com

Peptide Therapeutics Market Analysis, Growth, Trends and Forecasts to 2020 | Hexa Research

Rising cases of cancer and high incidence of a number of metabolic diseases propel the global Peptide Therapeutics Market. Other industry drivers are prevalence of lifestyle diseases, introduction of hybrid methods of peptides synthesis, growing global population, and improved healthcare infrastructure. A molecule containing two or more amino acids is known as a peptide. Therapeutic peptides are short amino acid monomer chains.

Peptides are commonly known as amide bonds. These are used to treat blood-based disorders, certain types of cancers, chronic ailments, CNS (central nervous system) disorders, and cardiovascular & respiratory anomalies. Growing importance of peptide therapeutics in the pharmaceutical market may significantly contribute to overall demand during the forecast period (2012 to 2020). However, changing customer needs and lack of regulatory standards hinder industry progress.

Browse Details of Report @  https://www.hexaresearch.com/research-report/peptide-therapeutics-industry

The worldwide peptide therapeutics market is categorized on the basis of technologies, applications, routes of administration, products, and regions. Based on technologies, the segments are HPPS (hybrid phase peptide synthesis), LPPS (liquid phase peptide synthesis), and SPPS (solid phase peptide synthesis). Owing to cost effectiveness and user-friendliness, SPPS was the largest contributor to the overall industry in 2013.On the basis of applications, the market is divided into respiratory, cancer, anti-infection, pain, metabolic, cardiovascular, dermatology, renal, gastro intestinal, and others. In 2013, peptide therapeutics were used extensively in cancer treatment. High incidence of cancer cases worldwide is expected to fuel this segment till 2020.

According to routes of administration, the industry is segmented into mucosal, pulmonary, parenteral, oral, and others. “Others” includes nasal and intradermal. Parenteral held the highest industry share in 2013. Based on products, the bifurcations are generic and innovative. Innovative peptides dominated the overall industry in 2013.

As per regions, the global peptide therapeutics market is categorized into Europe, Asia Pacific, North America, and Rest of the World. North America leads the global industry because of high per capita expenditure on healthcare, rising income levels, and improvements in healthcare infrastructure. The region receives substantial support from the government and also from a number of NGOs.

Asia Pacific may witness robust growth over the forecast period because of economic progress, favorable government initiatives, and growing population. Japan, China, and India are the three key regional drivers of the Asia Pacific market. Prominent companies operating in the global peptide therapeutics market are Eli Lilly and Company; Takeda Pharmaceutical Company Ltd.; Amylin Pharmaceuticals LLC; Bachem Holding AG; and Teva Pharmaceuticals.

Rhythm, a U.S. based biopharmaceutical company dealing in peptide therapeutics presented the phase 2 clinical trial assessment of setmelanotide in November 2016. Setmelanotide, a peptide drug, is the company’s melanocortin-4 receptor agonist that is generally used to treat LepR (leptin receptor) deficiency obesity. This is a rare genetic anomaly that leads to unrelenting hyperphagia and severe obesity. According to the company, this disorder affects nearly two thousand people in the U.S. on an annual basis.

Caused by deficiencies & defects in the MC4 pathway, LepR deficiency obesity affects people in their early childhood. The MC4 pathway in humans regulates appetite, energy expenditure, and homeostasis. Setmelanotide’s efficacy was tested by researchers when it was administered everyday by subcutaneous injection. Over a period of 22 weeks, a LepR patient lost weight by almost 20%.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinical-diagnostics-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Visit Our Blog: hexaresearch1.blogspot.com